[The development of ischemic damage to the myocardium and a review of methods which decrease it].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003326:Coronary Circulation; D005947:Glucose / Q000627:therapeutic use; D006324:Heart Arrest, Induced; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D010101:Oxygen Consumption; D012770:Shock, Cardiogenic / Q000517:prevention & control; D014665:Vasodilator Agents / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D002121:Calcium Channel Blockers; D014665:Vasodilator Agents; D006821:Hyaluronoglucosaminidase; D005947:Glucose
Vznik ischemického poskodenia myokardu a prehl'ad metód, ktoré ho zmensujú.